AccessibilityHelpAbout Us
PharmaCielo logo

PharmaCielo(OTC) PCLOF

Market Cap$9.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-99%
5 Year-96%
1 Year+84%
1 Month+19%
$0.04
+6.25%
+0.00Today
PharmaCielo last closing stock price
MetricPriceDate
Last closeUSD 0.042026-09-17
PharmaCielo stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.93%USD 0.042026-09-10
1 month+19.21%USD 0.042026-08-18
3 month-36.57%USD 0.072026-06-18
Year to date+14.25%USD 0.042025-12-30
1 year+83.98%USD 0.022025-09-17
3 year-78.98%USD 0.202023-09-18
5 year-95.64%USD 0.972021-09-17
Since inception-99.39%USD 6.992019-01-28

PharmaCielo Financials at a Glance

Market Cap

$9.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$3.61M

Net Income (TTM)

-CA$3.72M

EPS (TTM)

-$0.01

P/E Ratio

-3.15

Dividend

$0.00

Beta (Volatility)

0.70 (Low)

Price

$0.04

Volume

210

Open

$0.04

Previous Close

$0.04

Daily Range

$0.04 - $0.04

52-Week Range

$0.00 - $0.12

Estimated Earnings Date

Nov 26, 2026

PCLOF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PharmaCielo

PharmaCielo Ltd. specializes in the cultivation, processing, production, and distribution of medical-grade cannabis extracts, including THC. The company also offers telemedicine software solutions, serving a diverse clientele across Canada and Colombia.

Products and Services
  • Medical-grade cannabis extracts, including THC
  • Telemedicine software solutions for healthcare providers
  • Partnerships with health and wellness product manufacturers
Growth Outlook
  • Revenue increased to CAD 1.39 million in Q2 2026
  • Gross profit margin improved to 43.4% in Q2 2026
  • Strategic alliances enhance market reach and product offerings
Financial Highlights
  • Net income of CAD -1.44 million in Q2 2026
  • Operating income ratio of -38.8% in Q2 2026
  • Cash and cash equivalents of CAD 77,530 as of June 30, 2026
PharmaCielo Ltd. operates in the rapidly growing cannabis industry, focusing on high-quality medical-grade products. The recent revenue growth indicates a positive trend, with Q2 2026 showing a significant increase compared to previous quarters. The improvement in gross profit margin reflects better operational efficiency. However, the company continues to face challenges, as evidenced by the negative net income and operating income ratios. The strategic partnerships with various health and wellness manufacturers position PharmaCielo for potential growth in a competitive market. Investors may find the company's focus on quality and innovation appealing as the cannabis sector evolves.
AI Generated • Sep 9, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Marc Lustig, MBA

Website

www.pharmacielo.com

Headquarters

Toronto, ON M5C 1P1, CA

PCLOF Financials

Key Financial Metrics (TTM)

Gross Margin

37.20%

Operating Margin

-82.00%

Net Income Margin

-103.08%

Return on Equity

28.59%

Return on Capital

-117.01%

Return on Assets

-29.14%

Earnings Yield

-31.75%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$9.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

221.00M

Volume

210

Avg. Volume

40.43K

Financials (TTM)

Gross Profit

CA$1.22M

Operating Income

-CA$2.96M

EBITDA

-CA$427.33K

Operating Cash Flow

-CA$6.97M

Capital Expenditure

CA$7.12

Free Cash Flow

-CA$6.97M

Cash & ST Invst.

CA$77.53K

Total Debt

CA$18.22M

PharmaCielo Performance Analysis

PharmaCielo annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-12-31CAD 1,142,301-72.0%
20242024-12-31CAD 2,540,069122.4%
20252025-03-31CAD 2,281,423-10.2%
20262026-03-31CAD 1,835,064-19.6%
PharmaCielo sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30175.4%
Q42025-12-31-31.9%
Q12026-03-3118.9%
Q22026-06-3093.1%
PharmaCielo annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-12-31CAD -0.082.0%
20242024-12-31CAD -0.04-48.3%
20252025-03-31CAD -0.0520.3%
20262026-03-31CAD -0.01-70.8%
PharmaCielo sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-45.1%
Q42025-12-31129.7%
Q12026-03-31-400.0%
Q22026-06-30-6.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$1.39M

+330.9%

Gross Profit

CA$603.66K

+4614.2%

Gross Margin

43.41%

N/A

Market Cap

$9.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$35.05K

N/A

Employees

268

N/A

Net Income

-CA$1.44M

-43.9%

EBITDA

-CA$351.99K

+50.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CA$77.53K

+1084.6%

Total Debt

CA$18.22M

-12.5%

Accounts Receivable

CA$1.06M

+44.7%

Inventory

CA$1.75M

+16.5%

Long Term Debt

CA$0.00

N/A

Short Term Debt

CA$18.22M

-12.5%

Return on Assets

-29.14%

N/A

Return on Invested Capital

27.62%

N/A

Free Cash Flow

-CA$227.96K

-110.8%

Operating Cash Flow

-CA$227.96K

-110.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BBRRFBlueberries Medical Corp.
$0.01+0.00%
AVTBFAvant Brands Inc.
$0.40+4.81%
CPIVFCaptiva Verde Wellness Corp.
$0.02+0.00%
BUDZWEED, Inc.
$0.03-7.59%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$152.71-1.36%
NVDANvidia
$222.27+1.34%
AGNCAGNC Investment Corp.
$9.87-0.40%
INTCIntel
$108.60-0.18%

Questions About PCLOF

What is the current price of PharmaCielo?

PharmaCielo is trading at $0.04 per share.

What is the 52-week range for PharmaCielo?

Over the past 52 weeks, PharmaCielo has traded between $0.00 and $0.12.

How much debt does PharmaCielo have?

As of the most recent reporting period, PharmaCielo reported total debt of CA$12.84M.

How much cash does PharmaCielo have on hand?

PharmaCielo reported CA$54.62K in cash and cash equivalents in its most recent financial results.

What is PharmaCielo’s dividend yield?

PharmaCielo does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services